Who wrote this article?

Aakash Agarwal, Capitalmind's research team.

What topics does this article cover?

ALKEM, Pharmaceuticals, U.S. Food and Drug Administration, USFDA, USFDA Recall Information

Alkem Laboratories Recalls 1,739,000 Tablets Of Used For The Treatment Of Oral Diabetes

7 Dec 2016Aakash Agarwal1 min read

Quick Facts

What is "Alkem Laboratories Recalls 1,739,000 Tablets Of Used For The Treatment Of Oral Diabetes" about?
What category is this article in?: Stocks
Who wrote this article?: Aakash Agarwal, Capitalmind's research team.
When was this article published?: Published 7 December 2016.
How long does this article take to read?: 1 min read
What topics does this article cover?: ALKEM, Pharmaceuticals, U.S. Food and Drug Administration, USFDA, USFDA Recall Information

New Jersey, US based Ascend Laboratories has initiated a recall of Metformin Hydrochloride Tablets manufactured by Mumbai based Alkem Laboratories. The product was distributed in the US by Ascend Laboratories.

The Voluntary: Firm Initiated recall is for **1,739 bottles of USP 500 mg, 1000 tablets **and has been classified as a Class II Recall - a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

The recall has been initiated in the 5 states of US alone i.e. Alamaba, Florida, Gerogia, South Carolina and Tennessee.

The reason for recall mentioned by Ascend Laboratories was due to the presence of foreign Tablets/Capsules i.e. Amlodipine Tablets used in the treatment of high blood pressure (hypertension) were present in the bottles of Metformin Hydrochloride Tablets.

The batch recalled was from Lot 6121056 with an expiry date of 5/2019.